Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for credibility
Crystal clear? G 2/21 applied to polymorph patents (T 1994/22) Crystal clear? G 2/21 applied to polymorph patents (T 1994/22) Reviewed by Dr Rose Hughes on Monday, July 15, 2024 Rating: 5
The difference between the credibility and the unambiguous disclosure of a therapeutic effect (T 0209/22) The difference between the credibility and the unambiguous disclosure of a therapeutic effect (T 0209/22) Reviewed by Dr Rose Hughes on Sunday, June 02, 2024 Rating: 5
Make no bones about it: The "credibility test" has no place in the novelty assessment of second medical use claims (T 0558/20) Make no bones about it: The "credibility test" has no place in the novelty assessment of second medical use claims (T 0558/20) Reviewed by Dr Rose Hughes on Wednesday, August 30, 2023 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.